Itratop 200mg Capsule contains Itraconazole, a broad-spectrum antifungal agent effective against a variety of fungal infections. Itraconazole belongs to the triazole class of antifungals and works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting cell membrane integrity and leading to fungal cell death. This medication is indicated for the treatment of systemic and superficial fungal infections, including aspergillosis, histoplasmosis, blastomycosis, onychomycosis, and candidiasis. Itratop 200mg is typically administered orally and should be taken with food to enhance absorption. The dosage and duration of therapy depend on the type and severity of the infection, as well as patient response. Common adverse effects may include gastrointestinal disturbances such as nausea, vomiting, abdominal pain, and diarrhea, as well as headache and dizziness. Caution is advised in patients with hepatic impairment, and liver function tests should be monitored periodically during treatment. Itraconazole has potential drug interactions due to its effect on cytochrome P450 enzymes, so concomitant use with certain medications requires careful evaluation. Itratop 200mg Capsule should be used under medical supervision to ensure efficacy and safety.